Education
About Us
Working with TipRanks
Follow Us
JD Health International, Inc. (HK:6618)
:6618
6618 Stock Chart & Stats
HK$60.30
HK$0.45(1.61%)
At close: 4:00 PM EST
HK$60.30
HK$0.45(1.61%)
Day’s Range― - ―
52-Week RangeHK$27.15 - HK$71.70
Previous CloseN/A
Volume5.25M
Average Volume (3M)7.60M
Market Cap
HK$194.64B
Enterprise ValueHK$136.13B
Total Cash (Recent Filing)HK$49.31B
Total Debt (Recent Filing)HK$429.69M
Price to Earnings (P/E)37.5
Beta1.43
Next Earnings
Mar 05, 2026EPS Estimate
0.74Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.92
Shares Outstanding3,209,275,100
10 Day Avg. Volume6,883,323
30 Day Avg. Volume7,596,953
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)1.51
Price to Sales (P/S)1.43
P/FCF Ratio19.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$81.63Price Target Upside35.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthConsistent 24.5% YoY top-line growth demonstrates durable demand for JD Health's offerings and validates its go-to-market. Sustained revenue expansion provides operating leverage, supports continued investment in services and AI, and strengthens long-term cash generation capacity.
Large And Growing Active User BaseA 200 million active user base creates durable network effects and cross-sell potential for healthcare, pharmacy and subscription services. Scale improves unit economics, retention opportunities, and long-term monetization, underpinning sustainable revenue and competitive positioning.
Robust Balance Sheet And Cash GenerationHigh equity ratio, low leverage and positive free cash flow provide financial flexibility to fund R&D, AI integration and on-demand service expansion without overreliance on external financing. This resilience supports multi-year strategic execution and downside protection.
Bears Say
Rising Selling And Marketing ExpensesMaterial increases in customer acquisition spend can pressure long-term margins if unit economics don't improve. Persistently higher S&M reduces free cash flow available for strategic investment and could require sustained scale or productivity gains to restore margin expansion.
Slight Decline In Operating Cash FlowEven with positive free cash flow, a drop in operating cash flow signals potential volatility in cash conversion from core operations. If persistent, it could constrain capital allocation flexibility, slow reinvestment in tech/services, and make the business more sensitive to demand cycles.
High Concentration In Direct SalesHeavy reliance on direct sales concentrates channel and margin exposure to retail dynamics and inventory/fulfillment pressures. Limited diversification into higher-margin service revenue increases vulnerability to competitive retail pricing and weakens structural resilience of revenue mix.
JD Health International, Inc. News
6618 FAQ
What was JD Health International, Inc.’s price range in the past 12 months?
JD Health International, Inc. lowest stock price was HK$27.15 and its highest was HK$71.70 in the past 12 months.
What is JD Health International, Inc.’s market cap?
JD Health International, Inc.’s market cap is HK$194.64B.
When is JD Health International, Inc.’s upcoming earnings report date?
JD Health International, Inc.’s upcoming earnings report date is Mar 05, 2026 which is in 10 days.
How were JD Health International, Inc.’s earnings last quarter?
JD Health International, Inc. released its earnings results on Aug 14, 2025. The company reported HK$0.916 earnings per share for the quarter, missing the consensus estimate of HK$1.165 by -HK$0.249.
Is JD Health International, Inc. overvalued?
According to Wall Street analysts JD Health International, Inc.’s price is currently Undervalued.
Does JD Health International, Inc. pay dividends?
JD Health International, Inc. does not currently pay dividends.
What is JD Health International, Inc.’s EPS estimate?
JD Health International, Inc.’s EPS estimate is 0.74.
How many shares outstanding does JD Health International, Inc. have?
JD Health International, Inc. has 3,209,275,100 shares outstanding.
What happened to JD Health International, Inc.’s price movement after its last earnings report?
JD Health International, Inc. reported an EPS of HK$0.916 in its last earnings report, missing expectations of HK$1.165. Following the earnings report the stock price went down -1.966%.
Which hedge fund is a major shareholder of JD Health International, Inc.?
Currently, no hedge funds are holding shares in HK:6618
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
JD Health International, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$81.63 (35.38% Upside)
HK$81.63 (35.38% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
130.47%
12-Months-Change
Fundamentals
Return on Equity
8.52%
Trailing 12-Months
Asset Growth
19.01%
Trailing 12-Months
Company Description
JD Health International, Inc.
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
6618 Stock 12 Month Forecast
Average Price Target
HK$81.63
▲(35.38% Upside)
Technical Analysis
Rici Healthcare Holdings Ltd.
―
Jinxin Fertility Group Ltd.
―
Gushengtang Holdings Limited
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
Hygeia Healthcare Holdings Co., Ltd.
―
Options Prices
Currently, No data available
---